BREANNA KEITH: Open Payments
NPI 1871070763 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 32 payments from 11 companies in 2025. Trend: 2023 $597 · 2024 $577 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $183 |
| Novo Nordisk Inc | 6 | $119 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $15 |
Products named: UBRELVY, VRAYLAR, QULIPTA, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, Rybelsus.
Industry payments across IN — which companies pay providers there.
